Literature DB >> 12815622

Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice.

Dominique Meunier1, Josée Aubin, Lucie Jeannotte.   

Abstract

The Hox family of transcriptional regulators has been extensively studied for their role in axial and appendicular patterning. Genetic analyses have also unveiled Hox gene function in organogenesis and postnatal development. A phenotypical survey of the Hoxa5(-/-) mutant mice shows that the surviving mutants display symptoms of hypothyroidism, including transient growth retardation, and delayed eye opening and ear elevation. Thyroid gland morphogenesis initiates normally, but follicle formation and thyroglobulin processing are abnormal at late gestation. The expression of several molecular markers essential for thyroid gland formation and function, namely Nkx2.1, Pax8, and Titf2, is affected in the developing thyroid gland of Hoxa5(-/-) mutants. As a consequence, the expression of thyroid effector genes, including the thyroglobulin and thyroperoxidase genes, is perturbed. Our characterization reveals that the loss of Hoxa5 function transiently affects thyroid development in a non-cell autonomous manner. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815622     DOI: 10.1002/dvdy.10325

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  16 in total

1.  Impact of the loss of Hoxa5 function on lung alveogenesis.

Authors:  Isabel Mandeville; Josée Aubin; Michelle LeBlanc; Mélanie Lalancette-Hébert; Marie-France Janelle; Guy M Tremblay; Lucie Jeannotte
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

2.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 3.  Review: the role of neural crest cells in the endocrine system.

Authors:  Meghan Sara Adams; Marianne Bronner-Fraser
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

4.  Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.

Authors:  A M Ferrara; L De Sanctis; G Rossi; S Capuano; G Del Prete; E Zampella; P Gianino; A Corrias; G Fenzi; M Zannini; P E Macchia
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

5.  Origin of the ultimobranchial body cyst: T/ebp/Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid.

Authors:  Takashi Kusakabe; Nobuo Hoshi; Shioko Kimura
Journal:  Dev Dyn       Date:  2006-05       Impact factor: 3.780

6.  Partial functional redundancy between Hoxa5 and Hoxb5 paralog genes during lung morphogenesis.

Authors:  Olivier Boucherat; Séverine Montaron; Félix-Antoine Bérubé-Simard; Josée Aubin; Polyxeni Philippidou; Deneen M Wellik; Jeremy S Dasen; Lucie Jeannotte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

Review 7.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

8.  Multiple promoters and alternative splicing: Hoxa5 transcriptional complexity in the mouse embryo.

Authors:  Yan Coulombe; Margot Lemieux; Julie Moreau; Josée Aubin; Milan Joksimovic; Félix-Antoine Bérubé-Simard; Sébastien Tabariès; Olivier Boucherat; François Guillou; Christian Larochelle; Christopher K Tuggle; Lucie Jeannotte
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 9.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

10.  Early thyroid development requires a Tbx1-Fgf8 pathway.

Authors:  Gabriella Lania; Zhen Zhang; Tuong Huynh; Cinzia Caprio; Anne M Moon; Francesca Vitelli; Antonio Baldini
Journal:  Dev Biol       Date:  2009-01-20       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.